BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arantes LH Jr, Crawford J, Gascon P, Latymer M, Launay-Vacher V, Rolland C, Scotte F, Wish J. A quick scoping review of efficacy, safety, economic, and health-related quality-of-life outcomes of short- and long-acting erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia and chronic kidney disease anemia. Crit Rev Oncol Hematol 2018;129:79-90. [PMID: 30097240 DOI: 10.1016/j.critrevonc.2018.06.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Choi S(, Casias M, Tompkins D, Gonzalez J, Ray SD. Blood, blood components, plasma, and plasma products. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. Elsevier; 2019. pp. 373-86. [DOI: 10.1016/bs.seda.2019.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Ingrasciotta Y, Sultana J, Formica D, Ientile V, Aiello A, Chinellato A, Tari DU, Gini R, Pastorello M, Scondotto S, Cananzi P, Traversa G, Rossi M, Santoro D, Trifirò G; Italian Biosimilars Network (I-BioNetwork). Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? Pharmacoepidemiol Drug Saf 2021;30:65-77. [PMID: 33067914 DOI: 10.1002/pds.5152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Stanley IK, Schultz KL, Gardiner KM, Staatz CE. Evaluating the utilisation and expenditure patterns of erythropoietin stimulating agents and immunosuppressants in Australian chronic kidney disease patients. Journal of Pharmaceutical Health Services Research 2021;12:350-6. [DOI: 10.1093/jphsr/rmab027] [Reference Citation Analysis]
4 Silvestris N, Argentiero A, Cosmai L, Porta C, Gesualdo L, Brunori G, Brunetti O, Rampino T, Secondino S, Rizzo G, Pedrazzoli P. Management of targeted therapies in cancer patients with chronic kidney disease, or on haemodialysis: An Associazione Italiana di Oncologia Medica (AIOM)/Societa’ Italiana di Nefrologia (SIN) multidisciplinary consensus position paper. Critical Reviews in Oncology/Hematology 2019;140:39-51. [DOI: 10.1016/j.critrevonc.2019.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hanna RM, Streja E, Kalantar-Zadeh K. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther 2021;38:52-75. [PMID: 33123967 DOI: 10.1007/s12325-020-01524-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Teo GY, Rasedee A, Al-Haj NA, Beh CY, How CW, Rahman HS, Alitheen NB, Rosli R, Abdullah AH, Ali AS. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells. Saudi J Biol Sci 2020;27:653-8. [PMID: 32210684 DOI: 10.1016/j.sjbs.2019.11.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Rastogi A, Lerma EV. Anemia management for home dialysis including the new US public policy initiative. Kidney Int Suppl (2011) 2021;11:59-69. [PMID: 33777496 DOI: 10.1016/j.kisu.2020.12.005] [Reference Citation Analysis]
8 Hoshino J, Muenz D, Zee J, Sukul N, Speyer E, Guedes M, Lopes AA, Asahi K, van Haalen H, James G, Dhalwani N, Pecoits-filho R, Bieber B, Robinson BM, Pisoni RL, Lopes A, Pecoits-filho R, Combe C, Jacquelinet C, Massy Z, Stengel B, Duttlinger J, Fliser D, Lonnemann G, Reichel H, Wada T, Yamagata K, Pisoni R, Robinson B, Calice da Silva V, Sesso R, Speyer E, Asahi K, Hoshino J, Narita I, Perlman R, Port F, Sukul N, Wong M, Young E, Zee J. Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD. Journal of Renal Nutrition 2020;30:404-14. [DOI: 10.1053/j.jrn.2019.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]